Category: Company
Quick infos Trade prices Volume: Market Cap: 499.17M Prev closed: Open: 12 High: 12.16 Low: 11.84 52 week low: 11.83 52 week high: 34.71 Dividends: No Dividends Next ER: November 16, 2021
About the Company Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris and New York City.
Earnings History Date EPS / Forecast Revenue / Forecast March 14, 2022 November 16, 2021 - / -0.6629- / 15.62MNovember 4, 2021 -0.82 / -0.82348.31M / 11.14MAugust 5, 2021 -0.88 / -0.730114.62M / 11.1MBeat! May 6, 2021 -0.28 / -0.816727.97M / 7.81MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Dec 1, 2021 9.19 9.18 9.33
9.14
48.60K 6.61% Nov 30, 2021 8.62 8.75 8.99
8.15
348.67K 2.99% Nov 29, 2021 8.37 8.89 9.08
8.30
148.18K -3.68% Nov 26, 2021 8.69 8.58 8.78
8.53
81.71K -0.34% Nov 24, 2021 8.72 8.47 8.81
8.30
118.07K 4.56% Nov 23, 2021 8.34 8.48 8.51
8.17
240.22K -0.24% Nov 22, 2021 8.36 8.82 8.82
8.35
344.16K -6.17% Nov 19, 2021 8.91 9.08 9.10
8.80
204.34K -2.09% Nov 18, 2021 9.10 9.45 9.47
8.96
178.05K -3.6% Nov 17, 2021 9.44 9.69 9.81
9.16
214.90K -3.28% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:1999 Employees:122 News
Cellectis organise une conférence téléphonique pour présenter ses résultats financiers du deuxième trimestre 2021 le vendredi 6 août à 14h00 CET finance.yahoo.com Oct 8, 2021 4:34 pm MNTV, AUTL, ALLO and CLLS among after hours movers seekingalpha.com Oct 8, 2021 5:49 am
Monthly information on share capital and company voting rights finance.yahoo.com Sep 10, 2021 4:30 pm CLLS is at high risk of performing badly seekingalpha.com Aug 17, 2021 9:32 pm Cellectis SA (CLLS) Q2 2021 Earnings Call Transcript fool.com Aug 6, 2021 7:00 pm Cellectis EPS misses by $0.28, beats on revenue seekingalpha.com Aug 6, 2021 4:33 am
Monthly information on share capital and company voting rights finance.yahoo.com Aug 2, 2021 4:30 pm Cellectis SA (CLLS) Q3 2020 Earnings Call Transcript fool.com Mar 16, 2021 2:00 pm Cellectis SA (CLLS) Q4 2020 Earnings Call Transcript fool.com Mar 5, 2021 3:30 pm
2 Strong Buy Stocks Flirting With a Bottom finance.yahoo.com Jul 8, 2021 7:53 pm Cellectis outlines four new UCART preclinical programs; reveals .HEAL, a genome surgery platform seekingalpha.com Jun 15, 2021 3:16 pm
Cellectis Innovation Days event highlighted New Product Development, New Genome Surgery Platform .HEAL, and Manufacturing Capabilities finance.yahoo.com Jun 14, 2021 4:30 pm
Cellectis S.A. Reports Results from Annual Shareholders General Meeting Held on June 1, 2021 finance.yahoo.com Jun 2, 2021 2:30 am Sanofi and Cellectis partner for alemtuzumab in CAR T-cells trials seekingalpha.com May 12, 2021 4:52 am
Cellectis and Sanofi partner on alemtuzumab as lymphodepletion agent for allogeneic CAR-T finance.yahoo.com May 11, 2021 4:30 pm Cellectis EPS beats by $0.52, beats on revenue seekingalpha.com May 7, 2021 5:20 am
Cellectis Provides Business Update and Reports Financial Results for First Quarter 2021 finance.yahoo.com May 6, 2021 4:30 pm
Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2020 Financial Results finance.yahoo.com Apr 28, 2021 4:42 pm
Cellectis SA to Host Earnings Call finance.yahoo.com Apr 28, 2021 12:15 pm
The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding finance.yahoo.com Apr 28, 2021 7:52 am This company doesn't provide a dividend.
Key Persons CEO : André Choulika, PhD Talk about Cellectis SA below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.
A simple, straightforward guide to the fundamentals of technical analysis
